Keppra

Indicated For

partial focal seizures, epilepsy

About This Medication

# UCB Patient Assistance Program Patient Guide: How to Get Keppra (levetiracetam) at Low or No Cost Keppra (levetiracetam) is a commonly prescribed anticonvulsant medication used to treat epilepsy and seizures in adults and children. The **UCB Patient Assistance Program** offers this vital medication at low or no cost to eligible uninsured or underinsured patients who meet specific income and residency criteria.[1][4] ## About Keppra (Levetiracetam) **Keppra** is the brand name for levetiracetam, an antiepileptic drug (AED) that helps control partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. It works by calming overactive nerve signals in the brain to prevent seizures from occurring. Unlike some older AEDs, Keppra has a low risk of drug interactions and does not require routine blood monitoring for liver or kidney function in most cases, making it a first-line option for many patients with epilepsy.[1][10] Keppra comes in various forms, including immediate-release tablets (250 mg, 500 mg, 750 mg, 1000 mg), extended-release tablets, oral solution, and intravenous injection. Typical adult doses start at 1000 mg per day (500 mg twice daily) and may increase to 3000 mg per day based on response and body weight. Always follow your doctor's exact dosing instructions, as abrupt stopping can trigger seizures.[4] If you're struggling with epilepsy, consistent access to Keppra is crucial for seizure control, quality of life, and safety. The UCB Patient Assistance Program bridges the gap for those facing high costs, which can exceed $1,000 monthly without insurance.[3][10] ## Who Qualifies for the UCB Patient Assistance Program? The program is designed for patients who cannot afford their UCB medications due to financial hardship. Key eligibility requirements include:[1][4] - Reside in the **United States**, District of Columbia, or U.S. Territories (including Puerto Rico). - Be **uninsured**, **underinsured**, or insured but experiencing **significant financial hardship** despite coverage. - Household income at or below **300% of the Federal Poverty Level (FPL)**. - Have a valid prescription from a U.S.-licensed healthcare provider. - Additional product-specific criteria may apply for Keppra. **Note:** Medicare Part D patients with certain plans may qualify—apply to confirm. The program reserves the right to change rules without notice.[1][4] ## Income Eligibility Breakdown Eligibility hinges on **total household income** not exceeding **300% of the FPL**. This includes all sources like wages, Social Security, pensions, and alimony. If no income, provide a signed letter explaining this.[1][4] Use the table below for 2026 FPL guidelines (adjusted annually; verify current levels at healthcare.gov). For a household of your size, multiply the 100% FPL by 3. | Household Size | 100% FPL (Annual) | 300% FPL Limit (Annual) | 300% FPL Limit (Monthly) | |----------------|-------------------|--------------------------|---------------------------| | 1 | $15,060 | $45,180 | $3,765 | | 2 | $20,440 | $61,320 | $5,110 | | 3 | $25,820 | $77,460 | $6,455 | | 4 | $31,200 | $93,600 | $7,800 | | 5 | $36,580 | $109,740 | $9,145 | | Add per person | +$5,380 | +$16,140 | +$1,345 | *Example: A single person earning $3,500/month ($42,000/year) qualifies; $4,000/month ($48,000/year) does not.* Proof of income (tax returns, pay stubs, etc.) is **mandatory**.[4] ## Insurance Requirements - **Uninsured patients** (no prescription coverage) are prime candidates.[4] - **Underinsured** (high copays, deductibles, or coverage gaps) may qualify if facing financial hardship.[1] - **Medicare Part D**: Some plans allow eligibility—submit application for review.[4] - **Private insurance**: Possible if coverage doesn't cover costs adequately, but verify via UCBCares helpline.[1] Patients with government insurance like Medicaid typically do not qualify, as the program targets those without adequate coverage.[1][4] ## Step-by-Step Application Process Applying is straightforward but requires coordination with your doctor. Multiple methods available: mail, online portal, or phone assistance.[1][2][5] 1. **Check Eligibility**: Confirm residency, income <300% FPL, and insurance status. Call **(844) 599-2273** (UCBCares) for guidance.[1][10] 2. **Gather Documents**: - Proof of income (e.g., 2025 tax return, W-2s, pay stubs for 3 months, SSI award letter). - Government-issued ID. - Insurance cards (if applicable) or proof of denial/non-coverage. - Signed letter if no income.[1][4][5] 3. **Complete Application**: - **Patient Section**: Personal info, household size/income, signature.[2] - **Doctor Section**: Prescriber completes, attaches prescription for Keppra.[1][9] - Download form: ucb-usa.com/Patients/Financial-Assistance or PDF links.[3][4] 4. **Submit**: - **Mail**: To address on form. - **Online**: ucb-pap.enrollsource.com (upload docs).[5] - **Phone Help**: (844) 599-2273 for support.[1] 5. **Follow Up**: Note confirmation number; processing takes weeks.[2] **Tip**: Double-check for patient/doctor signatures and income proof to avoid delays.[2][4][9] ## Timeline and Delivery - **Processing**: 2-4 weeks typical, longer if docs incomplete. Call for status.[1][2] - **Approval**: Free or low-cost Keppra shipped **directly to your home** (90-day supply common).[program details] - **Duration**: Often 12 months, then reapply.[1] ## Alternatives if Denied or Ineligible - **UCBCares Helpline**: (844) 599-2273 for other UCB resources or copay cards.[1][6] - **Generic Levetiracetam**: Cheaper; ask doctor/pharmacy.[10] - **Other PAPs**: RxHope, RxAssist, or Epilepsy Foundation listings.[2][8][10] - **State Programs**: Check Medicaid expansion or epilepsy-specific aid.[10] - **NeedyMeds/PAN Foundation**: Broader assistance.[8] ## Disclaimer This guide summarizes publicly available info as of 2026 and is not official advice. Eligibility/rules change; contact UCB directly at (844) 599-2273 or ucb-usa.com for latest details. Consult your doctor before changing meds. UCB verifies all info and may deny/terminate benefits anytime. Not affiliated with UCB.[1][3][4]

Program information last verified: March 30, 2026